Nav: Home

Molecule's role in maintaining liver size and function revealed

August 01, 2017

A Japanese team led by Tokyo Medical and Dental University(TMDU) researchers identified a molecule called YAP that determines whether liver cells proliferate or are eliminated, depending on the presence or absence of injury, thus shedding light on how this organ maintains its structure and function

Tokyo, Japan - For organs to maintain a steady state and fulfill their intended functions, the rates at which the cells within them multiply or die off need to be equal. This balance must also be adjusted when events such as an injury or infection occur. However, the mechanisms by which such balance is achieved have remained obscure, including for the liver, which is particularly vulnerable to destabilization owing to its function in detoxifying the body.

In a major advance on this issue, a Tokyo Medical and Dental University(TMDU)-led team has shown that a molecule called YAP regulates the fate of liver cells called hepatocytes, determining whether they proliferate to boost the organ's bulk or are degraded and removed. This choice was shown to be dependent on whether the liver cells had been damaged, which deepens our understanding of how this organ maintains itself.

In their work, reported recently in the journal Nature Communications, the team used a range of different techniques to introduce different variants of the YAP gene into mouse liver. Earlier findings had shown that an activated form of YAP normally enters the nucleus of liver cells where it promotes the expression of genes that cause these cells to proliferate. However, here the team found that the effects on cell fate of introducing YAP into cells differed depending on whether a hydraulic pressure or a virus carrier was used, realizing that it was actually the injury caused by the hydraulic pressure itself that had spurred this difference.

"Once we suspected that cell injury was a key factor determining which effect YAP had on the liver cell population, we analyzed which type of liver injury caused YAP to induce cells to be eliminated rather than multiply using toxic chemicals that damage only specific liver cell types," says Hiroshi Nishina of the Department of Developmental and Regenerative Biology, TMDU. "We found that damage to both hepatocytes and cells called liver sinusoidal endothelial cells led to the induction of hepatocyte elimination by YAP, which provided a strong hint about the process behind this elimination."

Specifically, the team showed that YAP is activated upon damage to cells in the liver, leading to the migration of these cells to special blood vessels in the liver. There, they undergo apoptotic cell death and are engulfed and degraded by Kupffer cells, which are liver-specific immune cells.

"This shows how effectively the liver can regulate its own size and function," co-author Norio Miyamura says. "Without regulatory mechanisms like this, the liver would be much more susceptible to becoming enlarged or developing cancerous growths."

The obtained findings could also help explain the causes of liver diseases associated with dysregulation of some of the key processes that enable this organ to function.
-end-
The article "YAP determines the cell fate of injured mouse hepatocytes in vivo" was published in Nature Communications at doi: 10.1038/ncomms16017.

Tokyo Medical and Dental University

Related Hepatocytes Articles:

CRISPR-HOT: A new tool to 'color' specific genes and cells
Researchers from the group of Hans Clevers at the Hubrecht Institute have developed a new genetic tool to label specific genes in human organoids, or mini organs.
Magnetic nanomaterials become an effective treatment against liver fibrosis
Fibrosis may affect different body organs. It develops as a reaction to long-time inflammation and is supposed to isolate the inflammation site from surrounding tissues.
Regeneration mechanism discovered in mice could provide target for drugs to combat chronic liver disease
Researchers at the University of Cambridge have uncovered a novel molecular mechanism that allows damaged adult liver cells to regenerate, paving the way for design of drugs to boost regeneration in conditions such as cirrhosis or other chronic liver diseases where regeneration is impaired.
How hepatitis B and delta viruses establish infection of liver cells
Princeton University researchers have developed a new, scalable cell culture system that allows for detailed investigation of how host cells respond to infection with hepatitis B (HBV) and delta virus (HDV).
Researchers identify human protein that aids development of malaria parasite
Researchers in Japan have discovered that the Plasmodium parasites responsible for malaria rely on a human liver cell protein for their development into a form capable of infecting red blood cells and causing disease.
How viable is your liver after you die?
In a paper to be published in a forthcoming issue of TECHNOLOGY, a group of researchers from Harvard Medical School have done a study on the viability of donated livers and its correlation with donor demographics.
Cancer most frequently spreads to the liver; here's why
When cancer spreads to another organ, it most commonly moves to the liver, and now researchers at the Abramson Cancer Center of the University of Pennsylvania say they know why.
New therapeutic avenue in the fight against chronic liver disease
A recent study, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has introduced a novel targeted drug delivery system in the fight against cancer.
Real-time detection of cholesterol in liver-on-chip cultures of human liver cells
In a paper to be published in the September/December 2019 issue of TECHNOLOGY, a team of researchers from the IIT, Chicago, has developed a novel microfluidic device for measuring in real-time the cholesterol secreted from liver tissue-chip containing human hepatocytes.
Simple method rescues stressed liver cells
Isolated human hepatocytes are essential tools in preclinical and clinical liver research, but cell quality is highly variable.
More Hepatocytes News and Hepatocytes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.